Marcin L. Leja
Warsaw, MZ 02042, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 09, 2026
Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies.
Journal: Human molecular genetics
Published: October 25, 2024
Zebrafish in-vivo study reveals deleterious activity of human TBC1D24 genetic variants linked with autosomal dominant hearing loss.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 23, 2024
The Genetic Background of Hearing Loss in Patients with EVA and Cochlear Malformation.
Journal: Genes
Published: December 31, 2022
Searching for the Molecular Basis of Partial Deafness.
Journal: International journal of molecular sciences
Published: March 31, 2022
Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease.
Journal: Frontiers in immunology
Published: March 25, 2022
Update on CD164 and LMX1A genes to strengthen their causative role in autosomal dominant hearing loss.
Journal: Human genetics
Published: December 14, 2021
TBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss.
Journal: Scientific reports
Published: March 15, 2021
Analysis of major otosclerosis-associated variants in RELN and TGFB1 genes in Polish patients.
Journal: Archives of medical science : AMS
Published: December 23, 2019
First confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene.
Journal: Journal of translational medicine
Published: July 16, 2019
Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one.
Journal: Scientific reports
Published: March 26, 2019
Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Journal: European journal of medicinal chemistry
Published: June 22, 2017
Last Updated: 09/26/2026